ValoreQ4, 24Q1, 25Q2, 25Q3, 25Q4, 25TTMSpese di vendita, generali e amministrative953 M919 M959 M973 M1.12 B3.97 BRicerca e sviluppo247 M247 M244 M256 M266 M1.01 BReddito operativo-29 M519 M455 M882 M301 M2.16 BProventi non operativi, Totale-218 M-225 M-252 M-237 M-220 M-934 MOneri finanziari, al netto degli interessi capitalizzati——————Proventi non operativi, esclusi gli oneri finanziari-218 M-225 M-252 M-237 M-220 M-934 MEntrate/uscite straordinarie——————Utile al lordo delle imposte-247 M294 M204 M648 M92 M1.24 BQuota di utile001 M2 M12 M15 MImposte29 M74 M-78 M214 M-390 M-180 MInteressi di minoranza-58 M6 M01 M07 MAltri proventi/oneri al netto delle imposte——————Utile netto al lordo delle attività cessate-392 M214 M282 M433 M481 M1.41 BAttività cessate175 M00000Utile netto-217 M214 M282 M433 M481 M1.41 BRegolazione della diluizione——————Dividendi privilegiati——————Utile netto diluito attribuibile agli azionisti ordinari-217 M214 M282 M433 M480 M1.41 BUtile base per azione (EPS base)-0.190.190.250.380.411.23Utile diluito per azione (EPS diluito)-0.190.180.240.370.421.21Numero medio di azioni ordinarie in circolazione1.13 B1.14 B1.15 B1.15 B1.15 B4.58 BAzioni diluite in circolazione1.13 B1.16 B1.16 B1.16 B1.16 B4.65 BEBITDA-20 M1.3 B1.44 B1.77 B-1.95 B2.57 BEBIT-164 M1.16 B1.29 B1.63 B-2.09 B1.99 BCosto del fatturato2.11 B2.01 B2.07 B2.18 B2.06 B8.32 BAltri costi del venduto——————Ammortamento e svalutazione (liquidità)144 M145 M148 M144 M144 M581 M
Teva Pharmaceutical Industries Limited American Depositary Shar
Teva Pharmaceutical Industries Ltd. is an Israeli multinational pharmaceutical company. Teva specializes primarily in generic drugs, but other business interests include branded-drugs, active pharmaceutical ingredients and, to a lesser extent, contract manufacturing services and an out-licensing platform.
Teva's primary branded products include Austedo which is used for the treatment of chorea associated with Huntington's disease and tardive dyskinesia; and Ajovy, used for the preventive treatment of migraine in adults. Additional branded drugs sold by Teva include Copaxone, Bendeka and Treanda, all of which are primarily sold in the United States.
Teva is listed on the Tel Aviv Stock Exchange and the New York Stock Exchange. Its manufacturing facilities are located in Israel, North America, Europe, Australia, and South America. The company is a member of the Pharmaceutical Research and Manufacturers of America.
Teva Pharmaceuticals is the largest generic drug manufacturer in the world. Overall, Teva is the 26th largest pharmaceutical company in the world. Teva has a history of legal trouble in relation to collusion and price-fixing to inflate prices for drugs.